APA (7th ed.) Citation

Wang, M., Wu, M., Liu, M., Yan, Z., Wang, G., & Mao, D. Hyperprogression to camrelizumab in a patient with esophageal squamous cell carcinoma harboring EGFR kinase domain duplication. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Wang, Mei, Meihong Wu, Minglu Liu, Zhengqing Yan, Guoqiang Wang, and Dongliang Mao. Hyperprogression to Camrelizumab in a Patient with Esophageal Squamous Cell Carcinoma Harboring EGFR Kinase Domain Duplication. BMJ Publishing Group.

MLA (9th ed.) Citation

Wang, Mei, et al. Hyperprogression to Camrelizumab in a Patient with Esophageal Squamous Cell Carcinoma Harboring EGFR Kinase Domain Duplication. BMJ Publishing Group.